Perella Weinberg Partners Capital Management LP Boosted By $1.90 Million Its Johnson & Johnson (JNJ) Stake; Lazard Asset Management Has Lifted Its Cigna (CI) Position

Cigna Corporation (NYSE:CI) Logo

Perella Weinberg Partners Capital Management Lp increased Johnson & Johnson (JNJ) stake by 46.14% reported in 2018Q3 SEC filing. Perella Weinberg Partners Capital Management Lp acquired 13,793 shares as Johnson & Johnson (JNJ)’s stock rose 5.87%. The Perella Weinberg Partners Capital Management Lp holds 43,688 shares with $6.04 million value, up from 29,895 last quarter. Johnson & Johnson now has $360.59 billion valuation. The stock increased 0.22% or $0.29 during the last trading session, reaching $134.45. About 7.90 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 3.75% since February 14, 2018 and is uptrending. It has outperformed by 3.75% the S&P500. Some Historical JNJ News: 22/03/2018 – Probi: Probi has signed a long-term agreement with Cilag, a member of the Johnson & Johnson Family of Companies for the development of a probiotic product; 11/04/2018 – J&J, IMERYS ORDERED TO PAY PUNITIVE DAMAGES IN TALC CANCER CASE; 21/03/2018 – J.J. Redick Might Be the N.B.A.’s Most Meticulous Player; 16/03/2018 – J&J REPORTS BINDING OFFER FROM PLATINUM EQUITY TO BUY LIFESCAN,; 16/03/2018 – Johnson & Johnson’s LifeScan Makes Blood Glucose Monitoring Products; 07/03/2018 – IFM Therapeutics and Bristol-Myers Squibb Awarded 2017 Deal of the Year by Clarivate Analytics; 23/05/2018 – ADVISORY: JJ RUEST, CN INTERIM PRESIDENT, CEO, TO ADDRESS; 16/05/2018 – Since 2011, Johnson & Johnson’s sales have declined 20%. So, the 124-year-old brand is relaunching its baby-care products with more natural ingredients to appeal to health-conscious millennial moms; 17/04/2018 – Johnson & Johnson tops earnings, revenue expectations; 02/05/2018 – Johnson & Johnson Comes in at #1 on the 2018 DiversityInc Top 50 Companies List

Lazard Asset Management Llc increased Cigna Corp (CI) stake by 36.61% reported in 2018Q3 SEC filing. Lazard Asset Management Llc acquired 115,256 shares as Cigna Corp (CI)’s stock rose 10.58%. The Lazard Asset Management Llc holds 430,091 shares with $89.56M value, up from 314,835 last quarter. Cigna Corp now has $71.71B valuation. The stock increased 1.99% or $3.68 during the last trading session, reaching $188.8. About 2.39M shares traded. Cigna Corporation (NYSE:CI) has risen 0.04% since February 14, 2018 and is uptrending. It has outperformed by 0.04% the S&P500. Some Historical CI News: 19/03/2018 – Cramer also sits down with the CEOs of Cigna and Emerson Electric; 09/03/2018 – EXPRESS SCRIPTS HOLDING SAYS CIGNA HAS RECIPROCAL OBLIGATIONS TO PAY $1.6 BLN TERMINATION FEE TO CO IF MERGER DEAL TERMINATED UNDER CERTAIN CONDITIONS; 08/03/2018 – EXPRESS SCRIPTS HOLDING CO – TRANSACTION WAS APPROVED BY BOARD OF DIRECTORS OF EACH COMPANY; 08/03/2018 – Cigna to Buy Express Scripts in Deal Worth $67B, Including Debt; 08/03/2018 – EXPRESS SCRIPTS – CIGNA INTENDS TO FUND CASH PORTION OF DEAL THROUGH A COMBINATION OF CASH ON HAND, ASSUMED EXPRESS SCRIPTS DEBT AND NEW DEBT ISSUANCE; 09/03/2018 – Express Scripts: Cigna Entered Commitment for $26.7B Bridge Loan Facility for Deal Financing; 08/03/2018 – St. Louis Business: BREAKING: Cigna buying St. Louis County-based Express Scripts for $67 billion; 08/03/2018 – The $54 billion Cigna-Express Scripts deal is the latest move in an industry aiming to tackle soaring healthcare costs; 30/04/2018 – Fidelity Health Care Services Cuts Cigna, Buys More Molina; 09/03/2018 – MOODY’S REVIEWS EXPRESS SCRIPTS’ RATINGS; DIRECTION UNCERTAIN

Among 11 analysts covering Cigna (NYSE:CI), 10 have Buy rating, 0 Sell and 1 Hold. Therefore 91% are positive. Cigna had 12 analyst reports since September 17, 2018 according to SRatingsIntel. The stock has “Overweight” rating by Morgan Stanley on Thursday, December 13. Credit Suisse maintained Cigna Corporation (NYSE:CI) rating on Tuesday, September 18. Credit Suisse has “Outperform” rating and $237 target. On Friday, November 2 the stock rating was maintained by Barclays Capital with “Overweight”. BMO Capital Markets maintained the shares of CI in report on Friday, November 2 with “Market Perform” rating. The rating was maintained by Citigroup on Friday, November 2 with “Buy”. The rating was maintained by Morgan Stanley with “Overweight” on Tuesday, February 5. The rating was upgraded by Raymond James to “Outperform” on Thursday, January 3. The stock of Cigna Corporation (NYSE:CI) earned “Outperform” rating by Leerink Swann on Monday, November 19.

Lazard Asset Management Llc decreased 3.25 5/24 (Prn) stake by 1.00M shares to 4.00 million valued at $4.71M in 2018Q3. It also reduced Itau Unibanco H (NYSE:ITUB) stake by 60,018 shares and now owns 1.19M shares. Altria Group (NYSE:MO) was reduced too.

More notable recent Cigna Corporation (NYSE:CI) news were published by: Seekingalpha.com which released: “CIGNA Q4 Earnings Preview – Seeking Alpha” on January 31, 2019, also Finance.Yahoo.com with their article: “UnitedHealth Stock Is a Buy, but Keep an Eye on the External Risks – Yahoo Finance” published on February 13, 2019, Gurufocus.com published: “Jeff Auxier Establishes 4 New Holdings in 4th Quarter – GuruFocus.com” on February 13, 2019. More interesting news about Cigna Corporation (NYSE:CI) were released by: Streetinsider.com and their article: “After-Hours Movers 1/31: (SYMC) (DGII) (CY) Higher; (CVS) (CI) (AMZN) (more…) – StreetInsider.com” published on January 31, 2019 as well as Globenewswire.com‘s news article titled: “Analysis: Positioning to Benefit within Cigna, Alexion Pharmaceuticals, Synchrony Financial, Global Medical REIT, Investors Real Estate Trust, and CPI Card Group — Research Highlights Growth, Revenue, and Consolidated Results – GlobeNewswire” with publication date: January 25, 2019.

Investors sentiment decreased to 0.98 in Q3 2018. Its down 0.14, from 1.12 in 2018Q2. It fall, as 53 investors sold CI shares while 251 reduced holdings. 107 funds opened positions while 190 raised stakes. 217.73 million shares or 4.89% more from 207.58 million shares in 2018Q2 were reported. Bancorp Of Mellon owns 2.12 million shares. Highvista Strategies Limited Liability Corporation accumulated 0.23% or 2,400 shares. Plante Moran Advisors Ltd Company, Michigan-based fund reported 50 shares. Balasa Dinverno Foltz Lc holds 0.04% or 1,674 shares in its portfolio. Orbimed Limited Com invested 1.59% in Cigna Corporation (NYSE:CI). Kepos LP invested in 2.05% or 191,725 shares. John G Ullman & Assocs Inc accumulated 0.07% or 1,800 shares. The Colorado-based Employees Retirement Association Of Colorado has invested 0.06% in Cigna Corporation (NYSE:CI). Of Vermont holds 1,122 shares. New York State Common Retirement Fund owns 591,100 shares. Rhumbline Advisers holds 0.18% or 452,525 shares in its portfolio. Manchester Cap Ltd has 608 shares. Barton Inv Mngmt has invested 0.1% in Cigna Corporation (NYSE:CI). Lombard Odier Asset Mgmt (Europe) owns 2,541 shares. Narwhal Management has 0.69% invested in Cigna Corporation (NYSE:CI).

Since September 14, 2018, it had 0 insider buys, and 4 sales for $5.21 million activity. On Friday, September 14 the insider ZOLLARS WILLIAM D sold $46,101. Triplett Michael W had sold 2,825 shares worth $605,253. 21,189 Cigna Corporation (NYSE:CI) shares with value of $4.51M were sold by Sadler Jason D.

Perella Weinberg Partners Capital Management Lp decreased Apple Inc (NASDAQ:AAPL) stake by 26,171 shares to 50,900 valued at $11.49M in 2018Q3. It also reduced Perspecta Inc stake by 41,098 shares and now owns 149,963 shares. Enterprise Prods Partners L (NYSE:EPD) was reduced too.

Among 5 analysts covering Johnson \u0026 Johnson (NYSE:JNJ), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Johnson \u0026 Johnson had 7 analyst reports since October 11, 2018 according to SRatingsIntel. Citigroup maintained the stock with “Neutral” rating in Monday, October 22 report. The company was maintained on Wednesday, October 17 by Raymond James. Wells Fargo maintained the stock with “Outperform” rating in Monday, January 14 report. The rating was maintained by Credit Suisse with “Outperform” on Wednesday, October 17. The rating was maintained by Citigroup on Wednesday, January 2 with “Neutral”. The stock has “Equal-Weight” rating by Morgan Stanley on Wednesday, January 2. The stock has “Equal-Weight” rating by Morgan Stanley on Thursday, October 11.

Since August 27, 2018, it had 3 insider purchases, and 8 insider sales for $79.44 million activity. Sneed Michael E sold $3.91 million worth of Johnson & Johnson (NYSE:JNJ) on Monday, August 27. 3,643 Johnson & Johnson (NYSE:JNJ) shares with value of $536,638 were sold by Kapusta Ronald A. Another trade for 40,000 shares valued at $5.77M was made by Duato Joaquin on Wednesday, November 7. Shares for $100,050 were bought by MULCAHY ANNE M on Friday, December 14. The insider Gorsky Alex sold 264,465 shares worth $38.60 million. 166,695 shares were sold by Fasolo Peter, worth $24.41 million on Monday, December 3. 2,000 shares were bought by PRINCE CHARLES, worth $268,731.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson: P/E Matters – Seeking Alpha” on January 17, 2019, also Bizjournals.com with their article: “Sightbox CEO on life after acquisition and growth under J&J – Portland Business Journal” published on February 06, 2019, Seekingalpha.com published: “JNJ up 1% premarket on strong Q4 – Seeking Alpha” on January 22, 2019. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “JNJ’s TECNIS Eyhance IOL available in Europe – Seeking Alpha” published on February 04, 2019 as well as Streetinsider.com‘s news article titled: “Missouri Supreme Court Strikes Blow to Litigation Tourism, J&J (JNJ) Wins Court’s Block on Defect Trials, Court Limits Bundling of Out-of-State Plaintiffs – Bloomberg – StreetInsider.com” with publication date: February 13, 2019.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart